Industry
Roche Sells Drugs of Abuse Testing Business to Varian
In a move to divest a business whose market is not important to the company's current strategy, Roche Diagnostics has sold its worldwide nonclinical drugs of abuse testing (DAT) business to Varian, Inc. for an undisclosed amount. More...30 Nov -0001
DPC Granted License to Develop Cancer Diagnostics
A license to develop and commercialize diagnostic assays based on two novel prostate-specific proteins for detecting and monitoring prostate cancer and perhaps other cancers has been granted to Diagnostic Products Corp. by Compugen, Ltd. More...30 Nov -0001
SpectRx Regains Rights to Glucose Monitoring Technology
A research, development, and license agreement on continuous glucose monitoring technology with Abbott Laboratories has been terminated, according to an announcement by SpectRx, Inc., which has regained rights to the technology.More...
30 Nov -0001
In Other News
TriPath and AmeriPath to Develop Melanoma Assay
Alliance for Molecular Bladder Cancer Detection
Huge Growth in Asian In Vitro Diagnostic Markets
Alliance to Market HPV Test
Continued Growth Seen for MEDICA 2002
Glucose Monitoring Program Continues
Alliance to Develop Clinical Diagnostics
DakoCytomation Acquires Artisan Line from CytoLogix
Alliance for Test to Detect Early Kidney Disease
Alliance to Develop Cancer Assays
Fujirebio Acquires Rights to Ovarian Tumor Markers
Bayer to Acquire Visible Genetics, Inc.
Digene Calls Off Merger with Cytyc
Trinity Biotech to Acquire Hemostasis Business
Dako and Cytomation Announce Merger
Alliance to Develop Molecular Diagnostics
New Drug Assay Technology Licensed
Orlando to Host AACC Annual Meeting
Impac Acquires Intellidata
Alliance on Nannoarray Protein Assays
Alliance to Develop NAT Diagnostic System
Sigma-Aldrich to Sell Diagnostics Business
Bio-Rad Acquires Scottish Diagnostic Company
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.








